Tag: Calico Life Sciences
Calico Life Sciences Announces U.S. FDA Orphan Drug Designation for Investigational Treatment of Autosomal Dominant Polycystic Kidney Disease
SAN FRANCISCO, Nov. 5, 2025 /PRNewswire/ -- Calico Life Sciences LLC (Calico), a biotechnology organization focused...
Calico Appoints Philip R. Kym, Ph.D., as Head of Drug Discovery
SOUTH SAN FRANCISCO, Calif., Oct. 16, 2025 /PRNewswire/ -- Calico Life Sciences LLC (Calico), a biotechnology...
Calico Life Sciences Announces U.S. FDA Fast Track Designation for Investigational Treatment of Autosomal Dominant Polycystic Kidney Disease
SOUTH SAN FRANCISCO, Calif., Oct. 2, 2025 /PRNewswire/ -- Calico Life Sciences LLC (Calico), a biotechnology organization...

